Update of the Evolution of SARS-CoV-2 Infection, COVID-19, and Mortality in Mexico Until May 15, 2020: An Ecological Study
Nicolás Padilla-Raygoza *
School of Medicine, University of Celaya, Celaya, México.
Cuauhtémoc Sandoval-Salazar
Division of Health Sciences and Engineering, Department of Nursing and Obstetrics, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México.
Luis-Antonio Díaz-Becerril
School of Medicine, University of Celaya, Celaya, México.
Vicente Beltrán-Campos
Division of Health Sciences and Engineering, Department of Clinical Nursing, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México.
Daniel Alberto Díaz-Martínez
Ministry of Health, Guanajuato State, Guanajuato, Mexico.
Efraín Navarro-Olivos
Ministry of Health, Guanajuato State, Guanajuato, Mexico.
María de Jesús Gallardo-Luna
Ministry of Health, Guanajuato State, Guanajuato, Mexico.
Francisco J Magos-Vazquez
Ministry of Health, Guanajuato State, Guanajuato, Mexico.
Ma Guadalupe León-Verdin
Ministry of Health, Guanajuato State, Guanajuato, Mexico.
*Author to whom correspondence should be addressed.
Abstract
Aims: Disease for a novel coronavirus has been a big public health challenge around the world in the past several months. The aim of this study is to describe the epidemic and report the number of confirmed cases and deaths of disease for a novel coronavirus in Mexico until May 15, 2020.
Study Design: Ecological study.
Place and Duration of Study: Registries of confirmed cases for disease for a novel coronavirus in Mexican population during January and until May 15, 2020, from National System of Epidemiological Surveillance/ General Direction of Epidemiology/ Secretary of Health, Mexico.
Methodology: Based on the database of confirmed cases of disease for a novel coronavirus by Secretary of Health in Mexico, we collected data on age, gender, and deaths, and co-morbidities. As of May 15, 2020, 45,032 cases have been identified in Mexico.
Results: The first confirmed case in Mexico has been identified on January 8, 2020 and the incidence has been rising from the end of February and throughout March. The early confirmed cases were imported cases resulting from travel to USA, Italy, Germany, Spain, France and Singapore. No one travelled to China. No cases of community transmission have been reported. The cause-specific mortality rate was 10.59% and the possibility to death is three times more if comorbidities are in the patient.
Conclusion: The frequency of confirmed cases of disease for a novel coronavirus in Mexico are concerning and the health authorities in Mexico are waiting for the peak of the epidemiological curve to occur in May. The mortality is high with co-morbidities.
Keywords: SARS-CoV-2, COVID-19, infection, population, Mexico